Learning from Experience in RASwt mCRC Management: From Testing to Targeted Therapy


ASCO® 2024 Insights: "PanaMa Trial - FU/FA Maintenance Therapy With or Without Panitumumab in RAS Wild-Type mCRC"

311 views
June 10, 2024

Chapters

PanaMa Trial Design & Patient Demographics

00:00

Efficacy & Survival Outcomes

02:53

Comments 0
Login to view comments. Click here to Login